Preliminary results have fueled hope for a new cancer drug from Revolution Medicines while posing a test for the Trump ...

Three people have died at just one community centre on the outskirts of Senegal’s capital, Dakar, following US aid cuts to ...

Ardelyx maintains a robust cash position, near-breakeven operations, and strategic patent protection. Find out why ARDX stock is a Buy.

In an Iraq-like strategy, Donald Trump wants to destabilise Venezuela for oil while dismissing reports and intel ...

In contrast, by utilizing technology-driven tools more effectively, we can drive efficiencies, improve communication, and ...

Obesity drugs have become an increasingly popular method of weight loss but most are not covered by insurance for that purpose ...

More than two weeks after President Donald Trump said he would halt “all payments” to Colombia, there has not been any ...

Amgen on Tuesday reported quarterly financial results that beat Wall Street expectations as product sales rose 12%, ...

A biotech stock with strong FDA approval odds this November may see limited upside amid a full valuation and a pending lawsuit.

More than two weeks after President Donald Trump said he would halt “all payments” to Colombia, there has not been any ...

(Reuters) -Merck said on Tuesday that it has entered into an agreement to receive funds managed by Blackstone Life Sciences ...

Merck & Co. is taking full control of MK-8690, an investigational drug targeting inflammatory bowel diseases that was part of the drugmaker's $10.8 billion acquisition of Prometheus Biosciences in ...